Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00949390 · ClinicalTrials.gov registry record
Complementary and Alternative Medicine Usage Among Participants Enrolled in Phase I Oncology Clinical Trials
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 309
- Enrollment target
NCT00949390: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00949390 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 309 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00949390 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 309 participants
- Enrollment target
Study Summary
Primary Objective: · The primary objective is to estimate the prevalence of use of complementary and alternative medicine (CAM) in patients with advanced malignancies who are seen in the Phase I clinic at MD Anderson Cancer Center (MDACC). Secondary Objective: · Examine the association between prevalence of CAM use and demographic and socioeconomic characteristics (age, gender, race, income, and education level), participation in a phase I clinical trial, disease characteristics (diagnosis), patients' perceptions about their prognosis, physicians' information and permission for patients' CAM use, decision-making, and types of CAM used by patients.
Interventions
- BEHAVIORAL Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 309 participants |
| Start Date | 2009-07 |
| Est. Completion | 2016-04 |
What the finished NCT00949390 record still lists
NCT00949390 is an observational study that tracks outcomes without assigning an intervention. The registered 309 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire is the first listed.
NCT00949390 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00949390 about?
NCT00949390 is a clinical study titled "Complementary and Alternative Medicine Usage Among Participants Enrolled in Phase I Oncology Clinical Trials". Primary Objective: · The primary objective is to estimate the prevalence of use of complementary and alternative medicine (CAM) in patients with advanced malignancies who are seen in the Phase I clinic at MD Anderson Cancer Center (MDACC). Secondary Objective: · Examine the association between pr...
What is the current status of trial NCT00949390?
This trial is currently completed. The enrollment target is 309 participants. The study started on 2009-07. Estimated completion is 2016-04.
What interventions are being tested in trial NCT00949390?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00949390?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03011684 · 309 participants · Phase 3
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
- NCT06915233 · 309 participants · Phase 3
A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle
- NCT03039439 · 310 participants
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
- NCT04178018 · 310 participants · NA
Transvaginal Ultrasound and Photoacoustic Imaging of Ovary
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia